Key factors associated with the under-prescription of statins in elderly coronary heart disease patients: Results from the ELIAGE and ELICOEUR surveys

被引:24
作者
Cournot, Maxime
Cambou, Jean-Pierre
Quentzel, Steven
Danchin, Nicolas
机构
[1] INSERM, U558, Dept Epidemiol, F-31073 Toulouse, France
[2] Bristol Myers Squibb Co, Rueil Malmaison, France
[3] Hop Europeen Georges Pompidou, Paris, France
关键词
statins; elderly; non-prescription; coronary heart disease; pharmaco-epidemiology; observance; tolerance;
D O I
10.1016/j.ijcard.2005.06.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The reasons why statins are under-utilized in elderly patients remain poorly understood. The aim of this study was to identify the reasons given by cardiologist for the non-prescription of statins in elderly CHD patients. Methods: Two cross-sectional pharmaco-epidemiological surveys were carried out among French cardiologists. The sample consisted of 1148 coronary patients aged 35 to 69 years and 1489 patients aged >= 70 years. Patients' risk factors, medical history, treatments, lipid values and the physicians' various motives for the non-prescription of statins were recorded. Results: Patients not treated with statins reached 37% in the age-group >= 70 years and 14% in the age-group 35-69 years. The main reason given for statin non-prescription was the lack of a medical indication (2.5% of the age-group 35 -69 years and 14% of the age-group < 70 years). Among patients >= 70 years, the lack of indication was more often cited in the following conditions: 1) in very old patients (36% of lack of indication in the age-group > 85 years vs. 10% in 70-75 years), 2) when lipid values were not available (20% when data were not available vs. 9%) and 3) when the patient had no prior history of myocardial infarction (MI) (20% when no history of MI vs. 7%). These factors were not associated with lack of indication among patients < 70 years. History of intolerance or side effect was given for 1.3% and 14% of patients for each of the groups (35-69 and > 70) and poor overall patient adherence was cited in 1% and 2%, respectively. Conclusion: The primary reason for the under-prescription of statins in elderly coronary patients is the perceived lack of indication, which stresses the need of extensive guidelines for prescription in elderly patients. Several factors associated with this perception seem to be specific to the elderly. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 22 条
  • [1] Aronow W S, 2002, Am J Geriatr Cardiol, V11, P247, DOI 10.1111/j.1076-7460.2002.00816.x
  • [2] Use of cholesterol-lowering therapy by elderly adults after myocardial infarction
    Ayanian, JZ
    Landrum, MB
    McNeil, BJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (09) : 1013 - 1019
  • [3] Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
  • [4] Cournot M, 2004, ARCH MAL COEUR VAISS, V97, P841
  • [5] Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty:: results from the nationwide French PREVENIR survey
    Danchin, N
    Grenier, O
    Ferrières, J
    Cantet, C
    Cambou, JP
    [J]. HEART, 2002, 88 (02) : 159 - 162
  • [6] European guidelines on cardiovascular disease prevention in clinical practice -: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice
    De Backer, G
    Ambrosioni, E
    Borch-Johnsen, K
    Brotons, C
    Cifkova, R
    Dallongeville, J
    Ebrahim, S
    Faergeman, O
    Graham, I
    Mancia, G
    Cats, VM
    Orth-Gomér, K
    Perk, J
    Pyörälä, K
    Rodicio, JL
    Sans, S
    Sansoy, V
    Sechtem, U
    Silber, S
    Thomsen, T
    Wood, D
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (17) : 1601 - 1610
  • [7] Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
    DeWilde, S
    Carey, IM
    Bremner, SA
    Richards, N
    Hilton, SR
    Cook, DG
    [J]. HEART, 2003, 89 (04) : 417 - 421
  • [8] Effect of early initiation of statins on survival in patients with acute myocardial infarction (the USIC 5000 registry)
    Ferrières, J
    Cambou, JP
    Guéret, P
    Boutalbi, Y
    Lablanche, JM
    Hanania, G
    Genès, N
    Cantet, C
    Danchin, N
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (04) : 486 - 489
  • [9] Fitchett David, 2004, Can J Cardiol, V20 Suppl A, p7A
  • [10] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, R
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Cleeman, JI
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    Keller, SA
    Jehle, AJ
    [J]. CIRCULATION, 2002, 106 (25) : 3143 - 3421